Runs a network of super-speciality hospitals across NCR and North India, anchored in Noida and expanding into Delhi, Faridabad, Agra and Gurugram.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 16 | 16 | 66 | 66 | 86 | 96 | 96 | 96 |
| Reserves | 40 | 53 | 46 | 111 | 751 | 1.4k | 1.6k | 1.5k |
| Borrowings | 113 | 103 | 115 | 117 | 5 | 7 | 26 | 36 |
| Other Liabilities | 32 | 39 | 59 | 33 | 36 | 42 | 141 | 286 |
| Total Liabilities | 202 | 211 | 286 | 326 | 878 | 1.6k | 1.9k | 1.9k |
| AssetsFixed Assets | 134 | 132 | 122 | 121 | 133 | 161 | 852 | 393 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 153 | 110 | 18 |
| Investments | 33 | 34 | 47 | 47 | 67 | 234 | 21 | 534 |
| Other Assets | 34 | 45 | 117 | 159 | 679 | 1.0k | 873 | 996 |
| Total Assets | 202 | 211 | 286 | 326 | 878 | 1.6k | 1.9k | 1.9k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 21 | 24 | 26 | 27 | 26 | 16 | 89 | 95 |
| Cash from Investing | -36 | -8 | -4 | -18 | -9 | -167 | -298 | -383 |
| Cash from Financing | 11 | -20 | -23 | -7 | -6 | 241 | 347 | 215 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -86 | 20 | 23 | 21 | 17 | -18 | -116 | -21 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (53.6×) and current (85.3×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 15.1% growth and a 54× exit, ₹844 only delivers your return if you pay ₹476. The price is currently baking in 28% growth.
EPS grows 15.1%/yr for 5 years, then fades to 6% over 2, exits at 54×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 15.1% | 11.39 |
| FY28 | 15.1% | 13.12 |
| FY29 | 15.1% | 15.10 |
| FY30 | 15.1% | 17.38 |
| FY31 | 15.1% | 20.00 |
| FY32 | 10.5% ·fade | 22.11 |
| FY33 | 6.0% ·fade | 23.44 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.